Atlas Trials

Phase III Study in Refractory Behcet's Disease

Clinical trial NCT00995709 · COMPLETED

Trial details

NCT number
NCT00995709
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Behcet Disease
Start date
2009-10-01
Primary completion
2010-07-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.